The Healthcare Stage led a consulting project aimed at refining the clinical and commercial positioning of Inspira’s R&D asset within its target market. Through comprehensive interviews with practicing clinicians, the goal was to understand the market perspective, clinical needs, and future adoption potential of the technology.

One key aspect of this analysis was determining which patient populations would benefit most from the product. Given the versatility of the technology, it had the potential to serve different patient groups, and a major focus of the consultation was to clarify these possibilities. The conversations with clinicians explored when and why they would choose to use the product, the specific diseases and conditions it could address, and the clinical settings in which it would be most effective.

Additionally, the feedback helped identify potential barriers, such as concerns about efficacy and safety, that would need to be addressed during product development. Clinicians provided critical insights into what clinical results would be necessary to drive adoption, helping to shape both the product’s positioning and the messaging around its benefits.

This analysis gave Inspira Technologies a clearer understanding of their product’s future clinical positioning, the challenges they might encounter in gaining market acceptance, and the commercial opportunities available. By aligning their R&D efforts with these insights, Inspira was able to strategically position their asset for future success, ensuring it would meet the needs of the right patient populations and fit effectively into clinical practice.